Google Ads Structure for Multi-Compound Peptide Brands

The single biggest structural mistake we see in multi-compound peptide brand accounts is mixing every product into shared campaigns and ad groups. It's efficient to manage, but it means a policy flag on one compound's ad copy or landing page can trigger a review that touches your entire account, not just the flagged product. Compound-level segmentation is the fix, and it's worth building in from the start rather than retrofitting after a suspension.

Related: This builds on our core guide to advertising peptides on Google.

Why Shared Campaigns Increase Risk

Google's review systems don't always evaluate policy violations at the individual ad level in isolation, particularly for repeat or pattern-based flags. An account with a history of violations tied to one compound can see stricter, faster review applied to unrelated campaigns in the same account. Segmenting by compound limits how far a single flag's consequences spread.

Recommended Account Structure

Level	Structure
Campaign	One campaign per compound or tightly related compound family, not one campaign for the whole catalog
Ad group	Segmented by intent within each compound, e.g. informational vs. purchase-intent keywords
Landing pages	Compound-specific pages rather than a single catalog page serving all ads
Negative keywords	Shared list across the account for universally excluded terms, plus compound-specific exclusions per campaign

Naming Conventions That Make Audits Faster

Consistent naming, compound name, campaign type, and date launched, makes it dramatically faster to identify which specific campaign triggered a review when a flag does happen, and to isolate it without needing to pause unrelated campaigns while you investigate.

Budget Allocation Without Cross-Contamination

Set budgets at the campaign level per compound rather than one shared daily budget across the account, so scaling one compound doesn't require touching settings on others
Track conversion performance per compound separately, both for optimization and so you can see clearly if a specific product line is driving disproportionate policy friction
When testing a new compound, launch it as its own isolated campaign with a small budget rather than folding it into an existing, already-approved campaign

What This Looks Like When It Works

This same segmented approach, isolating campaigns by product line so a single compliance issue never cascades account-wide, is part of how we scaled a multi-product peptide brand from $8K to $148K/month at 4.6x ROAS. See the full case study.

Reviewing Account Structure Before You Add a New Compound?

We'll map out the campaign architecture for your specific product catalog before you launch, so growth doesn't come with shared-account risk.

Book a free 30-minute audit →

Or email directly: sveta@oney.studio

Oney Studio is a specialist Google Ads agency for peptide and research chemical brands. We build compliance-first account architecture that scales, from cold start to six-figure monthly revenue, without account-level policy flags.

Peptide Brand Google Ads Account Structure Across Multiple Compounds